CTLA4 and colitis: [11] illuminated that gut microbiota composition was involved in the colitis induced by anti-CTLA-4 therapy, which was triggered by the unlimited activation of T cells and simultaneous attenuation of a subset of Tregs to interact with the Fc domain of the CTLA-4 antibodies via receptors.